Allogeneic induced pluripotent stem cells derived Treg cell therapy (Bit Bio/BlueRock)

N/A

Report date: 2024/03/27 17:50:10

Base Information

Drug NameAllogeneic induced pluripotent stem cells derived Treg cell therapy (Bit Bio/BlueRock)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBit Bio LtdBluerock Therapeutics Lp
China Registration ClassN/A

Develop Information

Active CompaniesBluerock Therapeutics LpBit Bio Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A